Diabetes Research and Clinical Practice
Volume 76, Issue 2 , Pages 236-244 , May 2007

Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes

  • Hiroyuki Unoki

      Affiliations

    • Division of Applied Translational Research, Graduate School of Medicine, Chiba University, Chiba, Japan
    • ,
  • Hideaki Bujo

      Affiliations

    • Department of Genome Research and Clinical Application, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 43 226 2092; fax: +81 43 226 2095.
    • ,
  • Sho-ichi Yamagishi

      Affiliations

    • Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan
    • ,
  • Masayoshi Takeuchi

      Affiliations

    • Department of Pathophysiological Science, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan
    • ,
  • Tsutomu Imaizumi

      Affiliations

    • Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan
    • ,
  • Yasushi Saito

      Affiliations

    • Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, Chiba, Japan

Received 27 January 2006 ,Revised 21 August 2006 ,Accepted 1 September 2006.

References 

  1. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 1988;318:1315–1321
  2. Fukami K, Ueda S, Yamagishi S, Kato S, Inagaki Y, Takeuchi M, et al. AGEs activate mesangial TGF-β-Smad signaling via an angiotensin II type I receptor interaction. Kidney Int. 2004;66:2137–2147
  3. Miele C, Riboulet A, Maitan MA, Oriente R, Romano C, Formisano R, et al. Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase Cα-mediated mechanism. J. Biol. Chem. 2003;278:47376–47387
  4. Naitoh T, Kitahara M, Tsuruzoe N. Tumor necrosis factor-α is induced through phorbol ester- and glycated human albumin-dependent pathway in THP-1 cells. Cell Signal. 2001;13:331–334
  5. Hirata T, Unoki H, Bujo H, Ueno K, Saito Y. Activation of diacylglycerol O-acyltransferase 1 gene results in increased tumor necrosis factor-α gene expression in 3T3-L1 adipocytes. FEBS Lett. 2006;580:5117–5121
  6. Ramirez-Zacarias JL, Castro-Munozledo F, Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 1992;97:493–497
  7. Takeuchi M, Bucala R, Suzuki T, Ohkubo T, Yamazaki M, Koike T, et al. Neurotoxicity of advanced glycation end-products for cultured cortical neurons. J. Neuropathol. Exp. Neurol. 2000;59:1094–1105
  8. Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M, et al. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J. Biol. Chem. 2002;277:20309–20315
  9. Takeuchi M, Makita Z, Yanagisawa K, Kameda Y, Koike T. Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients. Mol. Med. 1999;5:393–405
  10. Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T, Kameda Y. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol. Med. 2000;6:114–125
  11. Yamagishi S, Fujimori H, Yonekura H, Yamamoto Y, Yamamoto H. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia. 1998;41:1435–1441
  12. Wu-Wong JR, Berg CE, Wang J, Chiou WJ, Fissel B. Endothelin stimulates glucose uptake and GLUT4 translocation via activation of endothelin ETA receptor in 3T3-L1 adipocytes. J. Biol. Chem. 1999;274:8103–8110
  13. Yamagishi S, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J. Biol. Chem. 2001;276:25096–25100
  14. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA. 2003;100:7265–7270
  15. Panahloo A, Yudkin JS. Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease. Coronary Artery Dis. 1996;7:723–731
  16. Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, Katagiri H, et al. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes. 2000;49:1700–1708
  17. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004;114:1752–1761
  18. Yamagishi S, Amano S, Inagaki Y, Okamoto T, Koga K, Sasaki N, et al. Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes. Biochem. Biophys. Res. Commun. 2002;290:973–978
  19. Wolffenbuttel BH, Giordano D, Founds HW, Bucala R. Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet. 1996;347:513–515

PII: S0168-8227(06)00420-7

doi: 10.1016/j.diabres.2006.09.016

Diabetes Research and Clinical Practice
Volume 76, Issue 2 , Pages 236-244 , May 2007

Article Tools

* Image Usage & Resolution